A PYMNTS Company

US: DuPont merger Senate hearings to focus on antitrust concerns

By  |  September 19, 2016

Antitrust experts differ on what to expect when a DuPont executive along with other agriculture leaders testify Tuesday morning before the US Senate.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    On the other hand, the Senate has no authority to block the proposed $130 billion merger between DuPont and The Dow Chemical, creating the United States’ largest agriculture market player.

    “This is theater,” said Roger Dennis, dean of Drexel University’s law school and a former U.S. Department of Justice antitrust attorney. “It will be fascinating to see how the senators use the hearing and the questions they ask, but nothing of substance comes out of these events.”

    But Salil Mehra, an antitrust professor at Temple University, said testimony from agriculture trade groups could raise concerns at the hearing that may factor into the Department of Justice’s review of the Dow and DuPont merger.

    “There could be commentary from farmers or customers that could play into the normal procedure of the merger review,” he said.

    Full Content: Delaware Online

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.